Literature DB >> 15359569

Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditions.

Frank K Bedu-Addo1, Catharine Johnson, Shanthini Jeyarajah, Ian Henderson, Siddharth J Advant.   

Abstract

PURPOSE: The purpose of this study was to investigate the physicochemical and structural characteristics of recombinant botulinum serotype B (rBoNTB(Hc)) under various conditions and to use the information in evaluating suitable purification process conditions.
METHODS: The solubility of rBoNTB(Hc) was evaluated at pH 4, 5, 6 7.5, 8, and 9. Secondary structure was evaluated using circular dichroism, and conformational stability was monitored using highsensitivity differential scanning calorimetry. Hydrophobic interaction chromatography, size exclusion chromatography-high performance liquid chromatography (SEC-HPLC), sodium dodecyl sulfate-poly acrylamide gel electrophoresis (SDS-PAGE), peptide mapping, and UV spectroscopy were used to monitor stability under the various conditions.
RESULTS: The secondary structure of rBoNTB(Hc) consists predominantly of beta-sheets. Solubility of rBoNTB(Hc) was lowest at its pI and highest at low and high pH. In the presence of NaCl, however, solubility decreased with increase in pH. Conformational and chemical stability are improved below pH 7.5. In the presence of 150 mM NaCl at high pH, conformational and chemical stability of rBoNTB(Hc) are further decreased. The study suggests that the purification process should minimize exposure of rBoNTB(Hc) to high pH and salt conditions.
CONCLUSIONS: Optimal stability of rBoNTB(Hc) is achieved at low pH. The biophysical and analytical studies provide us with an understanding of rBoNTB(Hc) stability behavior in solution and assists in developing efficient purification conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359569     DOI: 10.1023/b:pham.0000036908.70139.f1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

Review 1.  Instability, stabilization, and formulation of liquid protein pharmaceuticals.

Authors:  W Wang
Journal:  Int J Pharm       Date:  1999-08-20       Impact factor: 5.875

2.  Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.

Authors:  K J Potter; M A Bevins; E V Vassilieva; V R Chiruvolu; T Smith; L A Smith; M M Meagher
Journal:  Protein Expr Purif       Date:  1998-08       Impact factor: 1.650

3.  Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E.

Authors:  V Sathyamoorthy; B R DasGupta
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

4.  Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.

Authors:  S Bandyopadhyay; A W Clark; B R DasGupta; V Sathyamoorthy
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

5.  Induction of an immune response by oral administration of recombinant botulinum toxin.

Authors:  N Kiyatkin; A B Maksymowych; L L Simpson
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Contributions of tryptophan side chains to the far-ultraviolet circular dichroism of proteins.

Authors:  R W Woody
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

7.  Formulation design of acidic fibroblast growth factor.

Authors:  P K Tsai; D B Volkin; J M Dabora; K C Thompson; M W Bruner; J O Gress; B Matuszewska; M Keogan; J V Bondi; C R Middaugh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

8.  Development of recombinant vaccines for botulinum neurotoxin.

Authors:  L A Smith
Journal:  Toxicon       Date:  1998-11       Impact factor: 3.033

Review 9.  Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.

Authors:  G Schiavo; O Rossetto; C Montecucco
Journal:  Semin Cell Biol       Date:  1994-08

10.  Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

Authors:  M P Byrne; T J Smith; V A Montgomery; L A Smith
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more
  3 in total

Review 1.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

2.  Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer.

Authors:  Kasper Huus; Svend Havelund; Helle B Olsen; Marco van de Weert; Sven Frokjaer
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

3.  Effect of chemical stabilizers on the thermostability and infectivity of a representative panel of freeze dried viruses.

Authors:  Boris Pastorino; Cecile Baronti; Ernest A Gould; Remi N Charrel; Xavier de Lamballerie
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.